{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T20:03:05Z","timestamp":1790280185036,"version":"4.1.0"},"reference-count":10,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100012331","name":"LEO Foundation","doi-asserted-by":"publisher","award":["LF-OC-24-001567"],"award-info":[{"award-number":["LF-OC-24-001567"]}],"id":[{"id":"10.13039\/501100012331","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jidonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.jid.2026.07.030","type":"journal-article","created":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T14:51:27Z","timestamp":1786805487000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Physicochemical properties of phosphodiesterase-4 inhibitor orismilast and implications for new inhibitor design"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4504-8038","authenticated-orcid":false,"given":"Jimin","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3262-1237","authenticated-orcid":false,"given":"Victor S.","family":"Batista","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4011-8308","authenticated-orcid":false,"given":"Christopher G.","family":"Bunick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jid.2026.07.030_bib1","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1016\/j.str.2004.10.004","article-title":"Structural basis for the activity of drugs that inhibit phosphodiesterases","volume":"12","author":"Card","year":"2004","journal-title":"Structure"},{"key":"10.1016\/j.jid.2026.07.030_bib2","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1002\/cpdd.1209","article-title":"A single-center, open-label, parallel control study comparing the pharmacokinetics and safety of a single oral dose of Roflumilast and its active metabolite Roflumilast N-oxide in healthy Chinese and Caucasian volunteers","volume":"12","author":"Han","year":"2023","journal-title":"Clin Pharmacol Drug Dev"},{"key":"10.1016\/j.jid.2026.07.030_bib3","first-page":"18","article-title":"Structural insights: what makes some PDE4 inhibitors more effective in inflammatory dermatoses","volume":"18","author":"Issa","year":"2025","journal-title":"J Clin Aesthet Dermatol"},{"key":"10.1016\/j.jid.2026.07.030_bib4","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s13321-025-00976-8","article-title":"CardioGenAI: a machine learning-based framework for re-engineering drugs for reduced hERG liability","volume":"17","author":"Kyro","year":"2025","journal-title":"J Cheminform"},{"key":"10.1016\/j.jid.2026.07.030_bib5","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.ddtec.2004.11.007","article-title":"Lead- and drug-like compounds: the rule-of-five revolution","volume":"1","author":"Lipinski","year":"2004","journal-title":"Drug Discov Today Technol"},{"key":"10.1016\/j.jid.2026.07.030_bib6","doi-asserted-by":"crossref","DOI":"10.1002\/bmc.4973","article-title":"Simultaneous quantification and pharmacokinetic evaluation of Roflumilast and its N-oxide in cynomolgus monkey plasma by LC-MS\/MS method","volume":"35","author":"Qu","year":"2021","journal-title":"Biomed Chromatogr"},{"key":"10.1016\/j.jid.2026.07.030_bib7","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1093\/bjd\/ljae507","article-title":"Orismilast, a phosphodiesterase 4B\/D inhibitor, in moderate-to-severe atopic dermatitis: efficacy and safety from a multicentre randomized placebo-controlled phase IIb dose-ranging study (ADESOS)","volume":"192","author":"Silverberg","year":"2025","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2026.07.030_bib8","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s40257-022-00741-9","article-title":"Pharmacokinetics of roflumilast cream in chronic plaque psoriasis: data from phase I to phase III studies","volume":"24","author":"Thurston","year":"2023","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.jid.2026.07.030_bib9","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1016\/j.jid.2024.10.597","article-title":"Chemical, biochemical, and structural similarities and differences of dermatological cAMP phosphodiesterase-IV inhibitors","volume":"145","author":"Wang","year":"2025","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jid.2026.07.030_bib10","doi-asserted-by":"crossref","DOI":"10.3390\/ijms262211228","article-title":"Feature-guided machine learning for studying passive blood-brain barrier permeability to aid drug discovery","volume":"26","author":"Zhu","year":"2025","journal-title":"Int J Mol Sci"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X26027375?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X26027375?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T19:40:19Z","timestamp":1790278819000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X26027375"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":10,"alternative-id":["S0022202X26027375"],"URL":"https:\/\/doi.org\/10.1016\/j.jid.2026.07.030","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Physicochemical properties of phosphodiesterase-4 inhibitor orismilast and implications for new inhibitor design","name":"articletitle","label":"Article Title"},{"value":"Journal of Investigative Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jid.2026.07.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Society for Investigative Dermatology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}